ATARA BIOTHERAPEUTICS INC's ticker is ATRA and the CUSIP is 046513107. A total of 128 filers reported holding ATARA BIOTHERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.72 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $7,047,000 | +750.1% | 180,695 | +347.7% | 0.01% | +600.0% |
| Q1 2017 | $829,000 | -96.9% | 40,359 | -95.2% | 0.00% | -96.3% |
| Q3 2015 | $26,541,000 | -16.1% | 844,180 | +40.8% | 0.03% | -6.9% |
| Q2 2015 | $31,629,000 | +27.9% | 599,485 | +0.8% | 0.03% | +26.1% |
| Q1 2015 | $24,724,000 | +214.7% | 594,758 | +102.5% | 0.02% | +228.6% |
| Q4 2014 | $7,856,000 | – | 293,695 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Antipodean Advisors LLC | 800,000 | $11,656,000 | 5.38% |
| Consonance Capital Management LP | 5,238,218 | $76,321,000 | 4.57% |
| BRIDGER MANAGEMENT, LLC | 1,785,784 | $26,019,000 | 2.41% |
| Trellus Management Company, LLC | 150,000 | $2,186,000 | 2.37% |
| MAVERICK CAPITAL LTD | 6,754,102 | $98,407,000 | 2.07% |
| Redmile Group, LLC | 6,843,370 | $99,708,000 | 1.84% |
| Baupost Group | 9,922,030 | $144,564,000 | 1.80% |
| Camber Capital Management LP | 1,400,000 | $20,398,000 | 1.17% |
| Pinz Capital Management, LP | 161,100 | $2,347,000 | 1.08% |
| Artal Group S.A. | 2,500,000 | $36,425,000 | 1.02% |